Global Point-of-Care Testing (POCT) Market, By Product (Glucose Monitoring, Cardiometabolic Testing, Infectious Disease Testing, Coagulation Testing, Pregnancy and Fertility Testing, Tumor/Cancer Marker Testing, Urinalysis Testing, Cholesterol Testing, Hematology Testing, Drugs-of-Abuse Testing, Fecal Occult Testing), Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), Prescription (OTC Testing, Prescription-based Testing), Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse (DoA) Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing), End-Use (Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The global point-of-care testing (POCT) market is expected to witness market growth at a rate of 9.25% in the forecast period of 2021 to 2028 and is expected to reach USD 49.77 billion by 2028. Data Bridge Market Research report on point-of-care testing (POCT) market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the prevalence of infectious diseases is escalating the growth of point-of-care testing (POCT) market.
Point-of-care testing refers to medical diagnostic testing that is known to be conducted in or around the point of care. It allows medical practitioners to achieve precise, lab-quality and diagnostic results in real-time within minutes.
The rise in funding by multiple sources across the globe acts as one of the major factors driving the growth of point-of-care testing (POCT) market. The increase in the incidences of target diseases and infectious diseases among population such as coronavirus and increase in demand for POC tests due to the divisions such as operating room, cath labs, ICU, emergency room and neonatal intensive care units among others in order to provide effective and rapid patient care accelerate the point-of-care testing (POCT) market growth. The rise in demand for home healthcare encouraging manufacturers to commercialize portable products that are user-friendly and emergence of smartphone-oriented healthcare solutions, digital technologies and embedded vision-based solutions further influence the point-of-care testing (POCT) market. Additionally, rise in significance of POC diagnostics in environmental monitoring and public health, rise in number of CLIA-waived POC tests, increase in technological advancement and surge in healthcare expenditure positively affect the point-of-care testing (POCT) market. Furthermore, growth in provider awareness about novel technologies and rise in demand for POC tests with multiplexing capabilities extend profitable opportunities to the point-of-care testing (POCT) market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the products, pricing pressure owing to reimbursement cuts and budget constraints and stringent regulatory policies are the factors expected to obstruct the point-of-care testing (POCT) market growth. Lack of alignment with definitive central lab methods and reluctance to change existing diagnostic practices are projected to challenge the point-of-care testing (POCT) market in the forecast period of 2021-2028.
This global point-of-care testing (POCT) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on point-of-care testing (POCT) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Point-of-Care Testing (POCT) Market Scope and Market Size
The global point-of-care testing (POCT) market is segmented on the basis of product, technology, prescription, application and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the point-of-care testing (POCT) market is segmented into glucose monitoring, cardiometabolic testing, infectious disease testing, coagulation testing, pregnancy and fertility testing, tumor/cancer marker testing, urinalysis testing, cholesterol testing, hematology testing, drugs-of-abuse testing and fecal occult testing. Cardiometabolic testing is further segmented into cardiac markers, blood gas/electrolytes testing kits, hba1c testing kits and lipids testing. Infectious disease testing is further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections, respiratory infections testing kits and others. Cholesterol testing is further segmented into prothrombin time testing kits and activated clotting time testing kit.
- On the basis of technology, the point-of-care testing (POCT) market is segmented into lateral flow assays, dipsticks, microfluidics, molecular diagnostics, immunoassays, agglutination assays, flow-through, solid phase and biosensors.
- On the basis of prescription, the point-of-care testing (POCT) market is segmented into OTC testing and prescription-based testing.
- On the basis of application, the point-of-care testing (POCT) market is segmented into cardio metabolic testing, infectious disease testing, nephrology testing, drug-of-abuse (DoA) testing, blood glucose testing, pregnancy testing and cancer biomarker testing.
On the basis of end-use, the point-of-care testing (POCT) market is segmented into hospitals, diagnostic centers, research laboratories and home-care settings. Hospitals are further segmented into emergency department critical-care unit, general ward and others. Clinics are further segmented into physicians clinic and diagnostic clinic.
Global Point-of-Care Testing (POCT) Market Country Level Analysis
The global point-of-care testing (POCT) market is analyzed and market size insights and trends are provided by country, product, technology, prescription, application and end-use as referenced above.
The countries covered in the point-of-care testing (POCT) market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the point-of-care testing (POCT) market because of the rapidly increasing COVID-19 cases in the U.S. and Canada and rise in the prevalence of infectious diseases. Asia-Pacific is expected to witness the fastest growth during the forecast period of 2021 to 2028 because of the development of healthcare infrastructure, rise in the adoption of miniaturized models and measures and higher prevalence of chronic and targeted diseases in the region.
The country section of the point-of-care testing (POCT) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The global point-of-care testing (POCT) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for point-of-care testing (POCT) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point-of-care testing (POCT) market. The data is available for historic period 2011-2019.
Competitive Landscape and Point-of-Care Testing (POCT) Market Share Analysis
The global point-of-care testing (POCT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to point-of-care testing (POCT) market.
The major players covered in the point-of-care testing (POCT) market report are Abbott, F. Hoffmann-La Roche Ltd, Siemens AG, Beckman Coulter, Inc., BD, Johnson & Johnson Services, Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Medtronic, Accriva Diagnostics, Opti Medical, Sienco, Inc., Alpha Scientific Electronics, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics Inc., bioMérieux SA, Biomerica, Inc., Binx Health, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, Nova Biomedical among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Point-of-Care Testing (POCT) Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.